RSCF REFLECT SCIENTIFIC, INC.
Laboratory Apparatus & Furniture · OTC · SEC CIK 1103090 · Fiscal year ends 12/31
Financial factors as of 2024-09-30 (2024Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY25.6%
TTM net income YoY90.3%
TTM EPS YoY—
Revenue 3-yr CAGR-13.7%
Net income 3-yr CAGR—
Margins
Gross margin58.5%
Operating margin-3.6%
Net margin-1.7%
FCF margin—
EBITDA margin—
Returns
ROE-1.4%
ROA-1.2%
ROIC (approx.)-5.5%
Asset turnover0.68x
Leverage & solvency
Liabilities / assets11.1%
Debt / equity0.00x
Current ratio15.03x
Interest coverage—
Cash quality & payout
Operating cash flow / net income10.50x
Accruals ratio11.1%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 | FY20202020-12-31 | FY20192019-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.08M | $2.04M | $2.81M | $2.79M | $1.61M |
| Cost of revenue | $483,733 | $822,147 | $884,066 | $1.07M | $617,599 |
| Gross profit | $596,421 | $1.22M | $1.93M | $1.72M | $991,642 |
| R&D expense | $29,542 | $73,425 | $58,340 | $185,295 | $210,014 |
| SG&A expense | $388,640 | $419,589 | $436,399 | $350,477 | $408,359 |
| Operating income | -$467,278 | $90,098 | $827,800 | $651,005 | -$194,833 |
| Interest expense | — | — | — | $890 | -$755 |
| Pretax income | -$458,716 | $90,098 | $939,065 | $660,115 | -$195,588 |
| Income tax | $312 | $702 | — | — | $0 |
| Net income | -$459,028 | $89,396 | $939,065 | $660,115 | -$195,588 |
| EBITDA | — | — | $827,800 | $651,005 | -$190,853 |
| EPS (basic) | -0.01 | 0.00 | 0.01 | 0.04 | 0.00 |
| EPS (diluted) | -0.01 | 0.00 | 0.01 | 0.01 | 0.00 |
| Weighted avg. shares (diluted) | 85.22M | 85.44M | 85.49M | 84.74M | — |
| Balance sheet | |||||
| Cash & equivalents | $1.28M | $1.38M | $1.47M | $642,542 | $555,156 |
| Receivables | $108,191 | $129,329 | $175,649 | $340,427 | — |
| Inventory | $972,293 | $797,352 | $624,486 | $438,606 | — |
| Current assets | $2.37M | $2.33M | $2.31M | $1.45M | — |
| Goodwill | $60,000 | $60,000 | $60,000 | $60,000 | — |
| Total assets | $2.67M | $2.45M | $2.48M | $1.68M | — |
| Current liabilities | $596,366 | $149,592 | $241,849 | $242,629 | — |
| Total liabilities | $776,329 | $149,592 | $299,242 | $463,309 | — |
| Shareholders' equity | $1.89M | $2.30M | $2.18M | $1.21M | $553,026 |
| Shares outstanding | 85.66M | 85.21M | 84.99M | 84.74M | 84.74M |
| Cash flow statement | |||||
| Operating cash flow | -$103,976 | -$91,997 | $831,382 | -$25,218 | $335,869 |
| Investing cash flow | — | — | — | — | $0 |
| Financing cash flow | — | — | — | $112,604 | -$1,140 |
| Depreciation & amortization | — | — | $0 | $0 | $3,980 |
| Stock-based compensation | $55,000 | $27,500 | $27,500 | — | — |
Free plan shows the latest 5 periods; Pro shows all 14 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-19 06:28.